Identifying leak locations and mapping contaminant plumes enables effective source control and remediation. Using vertical ...

The results of the TROPION-Breast02 trial of the TROP2-targeting antibody-drug conjugate (ADC) were originally due to be ...

For at least a century outbreaks of meningitis have swept across a swathe of Africa running from Senegal to Ethiopia, killing ...

Abstract: The phase-only null beamforming synthesis is widely used in communication, radar, and sonar. Due to the phase-only constraint (constant modulus constraint), the problem is nonconvex and ...

Dyne Therapeutics' FORCE platform targets rare diseases with promise, but high valuation and trial risks limit upside. Find ...

What Happened? Shares of life sciences company Thermo Fisher (NYSE:TMO) jumped 2.9% in the afternoon session after the ...

Irish biotech start-up Aerska has raised $21 million (€18 million) in seed funding to help develop ribonucleic acid-based ...

As part of the collaboration, Secarna will leverage its proprietary, AI-empowered OligoCreator® discovery and development platform to identify promising oligonucleotide candidates, applying both ...

The Subject Expert Committee (SEC) on Oncology under the Central Drugs Standard Control Organization (CDSCO) has raised ...

Days after announcing the $100,000 visa application fee, the Trump administration proposed an overhaul of the H-1B visa ...

As one of the world’s largest biopharma companies, Pfizer ($PFE) is no stranger to leveraging market dynamics to benefit the ...

The DNA synthesis inhibitors market is projected to witness substantial growth in the coming years, driven by the rising ...